Skip to main content

Table 7 Relapse-free survival

From: Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status

 

Number

Months

Significance

All

18

  

Gender

 Male

8

7 (4.9–9)

0.912

 Female

10

9 (2.5–15)

Age

 < 50

16

9 (6.5–11.5)

0.064

 ≥ 50

2

5 (6.4–11.4)

TLC

 < 50

15

11 (6.7–15.3)

0.423

 ≥ 50

3

9 (6.4–11.5)

HB

 < 8

3

9

0.875

 ≥ 8

15

9 (4.3–13.6)

PLT

 < 50

11

9 (7.3–10.7)

0.552

 ≥ 50

7

11 (1.8–20)

Expression

 Low

8

7 (4.5–9.5)

0.04

 High

19

11

Blast

 < 50

5

9 (5.7–12.2)

0.421

 ≥ 50

13

9 (6.4–11.5)

Wild-FLT3

Wild-NPM1

8

9

0.194

Mutant-NPM1

1

9

FLT3-ITD

Wild-NPM1

6

12

Mutant NPM1

3

7